Bal Pharma Confirms No Deviation in Utilisation of ₹2.1 Cr Warrants Proceeds

Bal Pharma Limited has filed a statement confirming no deviation or variation in the utilization of funds raised through a preferential issue of warrants. The company raised ₹2,10,00,000/- (₹2.1 Crore) on September 7, 2026, at ₹21 per warrant. For the quarter ended September 30, 2026, the entire amount remains unutilized, and no funds were used during this period. This aligns with the original objects for which the funds were raised, specifically for a Greenfield API Manufacturing Facility at Yadgiri, Karnataka. The company has confirmed that the entire amount received is unutilized and remains in the company's bank account.